Boston Scientific Cuts Forecast on Product Slowdown and Competition - Boston Scientific (NYSE:BSX)

Boston Scientific beat second-quarter estimates but lowered its 2026 sales and earnings outlook as restructuring costs weighed on guidance.

Raccontata dabenzinga.com